Frontlight ResearchEarly access
CompletedPhase 1
Greater Occipital Nerve Blockade in Veterans With Post-concussion Headache: Sub-study 1
Key facts
- Who runs it
- Yale University
- Where
- West Haven, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 1
- People taking part
- 10 people enrolled
- Started
- 26 Jan 2024
- Ended
- 31 Dec 2025
- Type of study
- Interventional, 4 groups
- Treatments tested
- Bupivacaine Injection
- Record updated
- 20 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- United States Military Veterans within VA Connecticut Healthcare System
- Chronic post-traumatic headache per ICHD-3 criteria (i.e., headaches are continuing to occur three months after the head injury)
- At least two headache days per week
- MRI brain scan completed within the past 3 months if chronic PTH for less than one year, within the past year if chronic PTH for less than 5 years, and within 5 years if chronic PTH for more than 10 years
- Review of MRI and the medical record does not reveal another source for headache
Who cannot take part
- Other contraindication to bupivacaine; Allergy or adverse reaction (e.g., rash, cardiac effects) to amide anesthetics, such as lidocaine; Instruction from clinician to avoid amide anesthetics, such as lidocaine
- Skull defect
- Pregnant or lack of adequate birth control
Where in United States
- VA Connecticut Healthcare SystemWest Haven, United States
About the trial
What the trial wants to find out
The acute and subacute sensations that occur on the scalp with injection of different concentrations of bupivacaine for grater occipital nerve blockade will be compared. Each Veteran participant will be randomized to receive three different concentrations, which will be injected one week apart each.
The 4 groups in the trial
- Group 1Treatment being tested
bupivacaine 0.0%, 0.01%, and 0.05% in random order, one week apart each
Treatment: Bupivacaine Injection
- Group 2Treatment being tested
bupivacaine 0.1%, 0.05%, and 0.1% in random order, one week apart each
Treatment: Bupivacaine Injection
- Group 3Treatment being tested
bupivacaine 0.0%, 0.1%, and 0.5% in random order, one week apart each
Treatment: Bupivacaine Injection
- Group 4Treatment being tested
bupivacaine \[0.01% or 0.05%\], \[0.05% or 0.1%\], and 0.05% in random order, one week apart each
Treatment: Bupivacaine Injection
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Anesthetic Greater Occipital Nerve Blockade in Veterans With Post-Traumatic Headache: Sub-study 1
- Record updated
- 20 August 2026